# Implantable Cardioverter Defibrillator Versus Optimal Medical Therapy In Patients With Variant Angina Manifesting as Aborted Sudden Cardiac Death

Study · id `cardio:ct-nct02845531` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02845531](<https://clinicaltrials.gov/study/NCT02845531>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02845531

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 140 participants.

## Technical summary

Registry record NCT02845531. Randomized; no masking; primary purpose treatment. Start 2016-11-29 (actual); primary completion 2030-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 140 participants (planned count; ClinicalTrials.gov record NCT02845531, source copy `cardio:ctgov-nct02845531-2026-06-25`, retrieved 2026-10-26)
- Started: 2016-11-29 (actual) (ClinicalTrials.gov record NCT02845531, source copy `cardio:ctgov-nct02845531-2026-06-25`, retrieved 2026-10-26)
- Primary completion: 2030-12 (anticipated) (ClinicalTrials.gov record NCT02845531, source copy `cardio:ctgov-nct02845531-2026-06-25`, retrieved 2026-10-26)
- Completion: 2031-06 (anticipated) (ClinicalTrials.gov record NCT02845531, source copy `cardio:ctgov-nct02845531-2026-06-25`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT02845531, source copy `cardio:ctgov-nct02845531-2026-06-25`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02845531-2026-06-25`, retrieved 2026-10-26)

## The registry's words

- Brief title: Implantable Cardioverter Defibrillator Versus Optimal Medical Therapy In Patients With Variant Angina Manifesting as Aborted Sudden Cardiac Death
- Acronym: VARIANT ICD
- Condition: Angina Pectoris, Variant
- Condition: Sudden Cardiac Death
- Intervention (Device): Implantable Cardioverter Defibrillator
- Intervention (Drug): Optimal Medical Therapy
- Lead sponsor: Kee-joon Choi
- Lead sponsor class: OTHER
- Collaborator: CardioVascular Research Foundation, Korea
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Microvascular and vasospastic angina (`cardio:microvascular-and-vasospastic-angina`)
- Registry condition terms include this condition: Sudden cardiac arrest (`cardio:sudden-cardiac-arrest`)
- Registry lists this organization as a collaborator: CardioVascular Research Foundation, Korea (`cardio:org-cardiovascular-research-foundation-korea`)

## Provenance

Content hash: 5a5faf7e0580c49cc1be45f1cc79c55977a2a83f0e9ddc4e1a14d1b78630e72c
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
